Beyond Air Inc (XAIR)

$1.38 -0.05 (-3.50%)
Market Cap 11.05M
Revenue (ttm) 3.71M
Net Income (ttm) -46.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,256.87%
Debt to Equity Ratio 0.95
Volume 218,700
Avg Vol 4,114,052
Day's Range N/A - N/A
Shares Out 8.01M
Stochastic %K 4%
Beta 0.30
Analysts Sell
Price Target $11.50

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices
Sector: Healthcare
Phone: 516 665 8200
Address:
900 Stewart Avenue, Suite 301, Garden City, United States
PeteDaJoo
PeteDaJoo Nov. 16 at 3:08 PM
$XAIR The general consensus is that I got caught in a "pump n' dump"... Again Oh well... such is life.
1 · Reply
VernCapital
VernCapital Nov. 15 at 1:23 AM
$XAIR according to the 10Q Lisi and Carey $11.5m loan has paid them out $1.45m interest since March.
1 · Reply
VernCapital
VernCapital Nov. 15 at 1:19 AM
$XAIR beyond cancer down to last $1.5m - had $30M committed in 2022.
0 · Reply
BJFANC
BJFANC Nov. 14 at 7:53 PM
$XAIR Paid back over $10 million in milestones. To have the right to sell it as well.
0 · Reply
Prof_Gulliver
Prof_Gulliver Nov. 14 at 4:07 PM
$XAIR Lisi can keep firing his head of sales and CFO, but the fault lies with him and the fact no one wants his deficient Gen 1 crap machine. How this inept and delusional fabricator of "guidance" and "sales" can still be in charge is a mystery.
1 · Reply
VernCapital
VernCapital Nov. 14 at 2:08 AM
$XAIR by end of 2026 lungfit PH will have been approved for 4 years with annual revenue of $8M. Let that sink in.
1 · Reply
midnite_clyde
midnite_clyde Nov. 13 at 4:32 PM
$XAIR C'mon. Fixing those machines again? Too many unpleasant surprises. At least machine availability isn't a sales issue. Making too many soon-to-be obsolete units. "Our margin slipped back negative this quarter due to costs required to upgrade our existing fleet of devices and provisions for excess inventory."
0 · Reply
Say_Whaaaat
Say_Whaaaat Nov. 13 at 3:46 PM
$XAIR it's sad no one can come up with anything logical lol.
2 · Reply
PumpinFE
PumpinFE Nov. 13 at 1:40 PM
$XAIR can anyone provide one single thing to be bullish on? Real facts to be bullish?
1 · Reply
DonDon531
DonDon531 Nov. 12 at 11:31 PM
$XAIR gonna scoop up some more of it ever breaks 2$
0 · Reply
Latest News on XAIR
Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript

Nov 10, 2025, 6:31 PM EST - 6 days ago

Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 4:05 PM EST - 6 days ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 22, 2025, 8:00 AM EDT - 7 weeks ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 8, 2025, 3:55 PM EDT - 2 months ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 8:00 AM EDT - 2 months ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 20, 2025, 8:00 AM EDT - 3 months ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Beyond Air, Inc. (XAIR) Q1 2026 Earnings Call Transcript

Aug 12, 2025, 7:40 PM EDT - 3 months ago

Beyond Air, Inc. (XAIR) Q1 2026 Earnings Call Transcript

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 25, 2025, 8:00 AM EDT - 4 months ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jul 22, 2025, 7:30 AM EDT - 4 months ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript

Jun 17, 2025, 9:53 PM EDT - 5 months ago

Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript

Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know

Jun 17, 2025, 4:32 PM EDT - 5 months ago

Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 17, 2025, 4:01 PM EDT - 5 months ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Jun 16, 2025, 8:00 AM EDT - 5 months ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings

Jun 16, 2025, 7:20 AM EDT - 5 months ago

Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 20, 2025, 8:00 AM EDT - 6 months ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 21, 2025, 4:05 PM EDT - 7 months ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 15, 2025, 4:05 PM EDT - 7 months ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Apr 9, 2025, 4:05 PM EDT - 7 months ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 24, 2025, 4:05 PM EDT - 8 months ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Mar 11, 2025, 7:30 AM EDT - 8 months ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Mar 6, 2025, 4:05 PM EST - 9 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Beyond Air, Inc. (XAIR) Q3 2025 Earnings Call Transcript

Feb 10, 2025, 7:25 PM EST - 9 months ago

Beyond Air, Inc. (XAIR) Q3 2025 Earnings Call Transcript

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 10, 2025, 4:05 PM EST - 9 months ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Feb 5, 2025, 9:29 AM EST - 10 months ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 27, 2025, 4:05 PM EST - 10 months ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 24, 2025, 9:15 AM EST - 10 months ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript

Nov 11, 2024, 7:56 PM EST - 1 year ago

Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Oct 2, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:34 AM EDT - 1 year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:32 AM EDT - 1 year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 27, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 23, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jul 16, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript

Jun 24, 2024, 5:48 PM EDT - 1 year ago

Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 24, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

Jun 24, 2024, 3:32 AM EDT - 1 year ago

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

EPAC OMIC ITI STOK

Beyond Air® Appoints David Webster as Chief Commercial Officer

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

May 23, 2024, 4:09 PM EDT - 1 year ago

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

PeteDaJoo
PeteDaJoo Nov. 16 at 3:08 PM
$XAIR The general consensus is that I got caught in a "pump n' dump"... Again Oh well... such is life.
1 · Reply
VernCapital
VernCapital Nov. 15 at 1:23 AM
$XAIR according to the 10Q Lisi and Carey $11.5m loan has paid them out $1.45m interest since March.
1 · Reply
VernCapital
VernCapital Nov. 15 at 1:19 AM
$XAIR beyond cancer down to last $1.5m - had $30M committed in 2022.
0 · Reply
BJFANC
BJFANC Nov. 14 at 7:53 PM
$XAIR Paid back over $10 million in milestones. To have the right to sell it as well.
0 · Reply
Prof_Gulliver
Prof_Gulliver Nov. 14 at 4:07 PM
$XAIR Lisi can keep firing his head of sales and CFO, but the fault lies with him and the fact no one wants his deficient Gen 1 crap machine. How this inept and delusional fabricator of "guidance" and "sales" can still be in charge is a mystery.
1 · Reply
VernCapital
VernCapital Nov. 14 at 2:08 AM
$XAIR by end of 2026 lungfit PH will have been approved for 4 years with annual revenue of $8M. Let that sink in.
1 · Reply
midnite_clyde
midnite_clyde Nov. 13 at 4:32 PM
$XAIR C'mon. Fixing those machines again? Too many unpleasant surprises. At least machine availability isn't a sales issue. Making too many soon-to-be obsolete units. "Our margin slipped back negative this quarter due to costs required to upgrade our existing fleet of devices and provisions for excess inventory."
0 · Reply
Say_Whaaaat
Say_Whaaaat Nov. 13 at 3:46 PM
$XAIR it's sad no one can come up with anything logical lol.
2 · Reply
PumpinFE
PumpinFE Nov. 13 at 1:40 PM
$XAIR can anyone provide one single thing to be bullish on? Real facts to be bullish?
1 · Reply
DonDon531
DonDon531 Nov. 12 at 11:31 PM
$XAIR gonna scoop up some more of it ever breaks 2$
0 · Reply
Prof_Gulliver
Prof_Gulliver Nov. 12 at 10:08 PM
$XAIR With revenue barely growing due to CEO incompetence, and with basically no prospects for growth for more than a year, Lisi will be diluting and reverse splitting shareholders to death. By the time they pull the plug, a shareholder who had 1,000 shares at $10 a share a few years ago will probably end up with 3 shares at $2.00 -- if they’re lucky.
0 · Reply
Say_Whaaaat
Say_Whaaaat Nov. 12 at 9:15 PM
$XAIR speaking of dilution... They just added 3 million shares...
0 · Reply
Say_Whaaaat
Say_Whaaaat Nov. 12 at 9:02 PM
$XAIR in all seriousness, what could turn this around for us? It seems like we are dependent on the Gen 2 model getting approved and that could take some time. Positive cancer news only bumps up SP for a day. It just seems like it's doomed at this point... I want to stick around for cancer but it doesn't seem like it'll stay afloat until then. They only have cash into 2027 with the new loan and they could end up issuing a ton of shares and the lower this goes, the more shares will be issued...
1 · Reply
45IQ
45IQ Nov. 12 at 4:50 PM
$XAIR Watching pumpers scalp this stock w generic bullshit every other week:
1 · Reply
Heywood_Jablomi
Heywood_Jablomi Nov. 12 at 2:33 PM
$XAIR In
0 · Reply
kavkav
kavkav Nov. 12 at 2:28 PM
$XAIR מה אתה ממליצים לעשות עם המנייה הזאת?
1 · Reply
pow7904
pow7904 Nov. 12 at 2:18 PM
$XAIR
0 · Reply
MavisBeacon
MavisBeacon Nov. 12 at 5:24 AM
$XAIR
2 · Reply
NextRunnerTV
NextRunnerTV Nov. 12 at 3:06 AM
$XAIR Start of the bottom
0 · Reply
NextRunnerTV
NextRunnerTV Nov. 12 at 2:51 AM
$MBIO $XAIR $AMZE $TRUG https://www.tiktok.com/@nextrunnertv/video/7571665460014451981
0 · Reply
MavisBeacon
MavisBeacon Nov. 11 at 9:44 PM
$XAIR $4 tomorrow
2 · Reply
DonDon531
DonDon531 Nov. 11 at 7:58 PM
$XAIR warrant exercise price adjusted to 1.95 it looks like, according to the filings.
0 · Reply